SUN Pharmaceutical Industries Limited Citalopram Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Citalopram Export Records India — #3 Exporter, 463 Shipments, $23.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

SUN Pharmaceutical Industries Limited — Citalopram Exporter #3 | $23.0M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Citalopram Exporter Profile

Indian Pharmaceutical Exporter · #3 for Citalopram · $23.0M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #3 Indian exporter of Citalopram with $23.0M in export value and 463 verified shipments. SUN Pharmaceutical Industries Limited holds a 9.0% market share in Citalopram exports across 11 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Citalopram Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Citalopram export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Citalopram?

Country	Value	Shipments	Share
BELGIUM	$3.4M	208	31.1%
BRAZIL	$2.7M	108	25.3%
SRI LANKA	$1.3M	49	12.4%
MOROCCO	$1.1M	27	10.0%

Who Are the Top Buyers of Citalopram from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$2.9M	179
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$2.1M	71
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$696.1K	27
RANBAXY (THAILAND) CO. LTD,	THAILAND	$553.0K	15
M/S. SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$452.5K	12
M/S. RANBAXYFARMACEUTICA LTDA	BRAZIL	$350.0K	7
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$317.8K	20
M S SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$300.0K	6
TO THE ORDER	SRI LANKA	$217.8K	6
M/S. SUN PHARMA CANADA INC	CANADA	$163.3K	5

SUN Pharmaceutical Industries Limited supplies Citalopram to 46 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) and MYIT MAHAR TRADING CO., LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Citalopram Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
CITALOPRAM TAB 20MG PACK:BOX30s BATCH:DF	$650.0K	13
CITALOPRAM TAB 20MG PACK:BOX30s BATCH:	$350.0K	7
NEXITO 5 TABLETS (Escitalopram Oxalate T	$258.8K	8
ESCITALOPRAM OXALATE TABLETS 10MG PACK:	$247.1K	5
ESCITALOPRAM OXAL TAB 10MG PACK:BOX3X10s	$214.7K	6
CILENTRA TABS 10MG(ESCITALOPRAM OXALATE	$200.0K	4
ESCITALOPRAM OXALATE TABLETS 10MG ( SERODEPS TAB 10MG ) EACH FILM-COATED TABLETCONTAINS: ESCITALOPRAM OXALATE EQ. TO ES	$199.2K	6
NEXITO 10 MG TABLETS(ESCITALOPRAM OXALAT	$198.4K	7
ESCITALOPRAM OXALATE TABLETS 10MG ( ESCI	$156.8K	13
CILENTRA TABS 10MG (ESCITALOPRAM OXALATE	$154.3K	4

SUN Pharmaceutical Industries Limited exports 285 distinct Citalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CITALOPRAM TAB 20MG PACK:BOX30s BATCH:DF with 13 shipments worth $650.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Citalopram Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	AUROBINDO PHARMA LTD	$28.0M	1,035	25	$27.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$23.0M	463	11	$49.6K
4	TORRENT PHARMACEUTICALS LTD	$17.3M	345	15	$50.0K
6	AUROBINDO PHARMA LIMITED	$13.5M	420	14	$32.0K

SUN Pharmaceutical Industries Limited ranks #3 among 257 Indian Citalopram exporters. Average shipment value of $49.6K compared to the market average of $579.1K. The closest competitors by value are AUROBINDO PHARMA LTD and TORRENT PHARMACEUTICALS LTD.

Which Indian Ports Ship Citalopram Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	779	10.6%
SAHAR AIR	684	9.3%
NHAVA SHEVA SEA (INNSA1)	609	8.3%
HYDERABAD ICD	593	8.0%
HYDERABAD ICD (INSNF6)	411	5.6%
HYDERABAD AIR	336	4.6%
DELHI AIR CARGO ACC (INDEL4)	334	4.5%
DELHI AIR	309	4.2%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Citalopram Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 475 individual customs records matching SUN Pharmaceutical Industries Limited exporting Citalopram, covering 285 formulations to 11 countries via 46 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 736+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Citalopram

Citalopram

SUN Pharmaceutical Industries Limited — Citalopram Exporter Profile

SUN Pharmaceutical Industries Limited — Citalopram Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Citalopram?

Who Are the Top Buyers of Citalopram from SUN Pharmaceutical Industries Limited?

What Is India's Total Citalopram Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Citalopram Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Citalopram Exporters?

What Citalopram Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Citalopram to Key Markets

Brazil — ANVISA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Citalopram Exporters?

Which Indian Ports Ship Citalopram Exports?

What Other CNS & Psychiatric Products Does SUN Pharmaceutical Industries Limited Export?

Citalopram — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Citalopram Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Citalopram Export Data from SUN Pharmaceutical Industries Limited

Citalopram Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source